Sapphire Bioscience Holding ApS — Credit Rating and Financial Key Figures

CVR number: 38599917
Industriparken 39, 2750 Ballerup

Income statement (kDKK)

2021
2022
2023
Fiscal period length121212
Net sales
Gross profit-12.00-64.00-49.00
EBIT-12.00-64.00-49.00
Other financial income36 129.0044 424.0028 379.00
Other financial expenses- 291.00- 628.00- 266.00
Pre-tax profit35 826.0043 732.0028 064.00
Income taxes-1.0010.00-42.00
Net earnings35 825.0043 742.0028 022.00

Assets (kDKK)

2021
2022
2023
Intangible assets total
Tangible assets total
Holdings in group member companies143 847.00188 146.00156 953.00
Investments total143 847.00188 146.00156 953.00
Long term receivables total
Inventories total
Current amounts owed by group member comp.8 537.0024 230.00
Prepayments and accrued income4.005.004.00
Current other receivables672.003.00
Current deferred tax assets2 857.009 631.003 493.00
Short term receivables total11 398.0034 538.003 500.00
Cash and bank deposits193.001 233.00269.00
Cash and cash equivalents193.001 233.00269.00
Balance sheet total (assets)155 438.00223 917.00160 722.00

Equity and liabilities (kDKK)

2021
2022
2023
Share capital15 878.0015 878.0015 878.00
Shares repurchased31 755.00
Other reserves96 744.00141 476.00111 410.00
Retained earnings-4 116.00-43 894.00- 998.00
Profit of the financial year35 825.0043 742.0028 022.00
Shareholders equity total144 331.00188 957.00154 312.00
Non-current liabilities total
Current trade creditors31.0040.0025.00
Current owed to group member8 350.0024 759.004 500.00
Short-term deferred tax liabilities2 716.004 650.001 875.00
Other non-interest bearing current liabilities10.005 511.0010.00
Current liabilities total11 107.0034 960.006 410.00
Balance sheet total (liabilities)155 438.00223 917.00160 722.00
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.